Robert Uzzo, MD,CEO,MBA

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    Argos
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/08/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (Oncology)
    Ineligible company: 
    GSK
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/08/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (General Urology)
    Ineligible company: 
    Amgen
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/08/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Consultant or Advisor (General Urology)
    Ineligible company: 
    UroGen Pharma
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/08/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Meeting Participant or Lecturer (General Urology)
    Ineligible company: 
    Janssen
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    06/08/2022
Return to Annual Review Course (2022)